tirzepatide pediatric FDA expands use for mounajro in patients with type ii diabetes DOI 10.1016/S0140-6736(25)01774-X #insulinresistance #diabetes #medical #nursing #glp Mounjaro (tirzepatide) - Diabetes &
Description
Love the fast service and quality
Lancet 392, 21802193
New onset of genital pain or discomfort Pain during sex is never normal and always warrants evaluation regardless of what medication you are taking
The key advantages over oral semaglutide include no fasting requirement, no water restriction, and potentially better tolerability based on the clinical trial safety profile
